Home Capital Investing ideas

Hyphens Pharma gears up for growth with product pipeline, Vietnam focus

Samantha Chiew
Samantha Chiew7/9/2019 12:28 PM GMT+08  • 3 min read
Hyphens Pharma gears up for growth with product pipeline, Vietnam focus
SINGAPORE (July 9): Since its IPO in May last year, Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group, has gradually been building up its presence, both locally and in the region.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (July 9): Since its IPO in May last year, Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group, has gradually been building up its presence, both locally and in the region.

In 2018, Hyphens launched five products but more are expected this year with two dermatological products – Ceradan Advanced and TDF Fairence T-Complex – pending commercialisation.

According to Hyphens, Ceradan Advanced could be a potential bestseller given the product has a pH-balancing mechanism and contains ceramide which forms a barrier on the skin and helps it retain moisture.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now